Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metatranscriptomic Markers As A Predictor of Colonic Neoplasia at the Time of Colonoscopy

NCT07786818 is registered in ClinicalTrials.gov with Viome as lead sponsor.

NCT NCT07786818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07786818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metatranscriptomic Markers As A Predictor of Colonic Neoplasia at the Time of Colonoscopy
Lead sponsor
Viome
Phase
Observational
Overall status
Recruiting
Start date
December 20, 2025
Completion date
January 30, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal polyps